Mark A. Ainsworth

Odense, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Personalised treatment in biologically naive patients with Crohn's disease: a systematic review of the last 10 years.

Personalised treatment in biologically naive patients with Crohn's disease: a systematic review of the last 10 years.

Journal: Scandinavian journal of gastroenterology

Published: March 28, 2026

Identifying Genetic Factors Influencing the Development of Anti-Drug Antibodies in Inflammatory Bowel Disease: A Scoping Review.

Identifying Genetic Factors Influencing the Development of Anti-Drug Antibodies in Inflammatory Bowel Disease: A Scoping Review.

Journal: Journal of inflammation research

Published: October 01, 2025

Title Not Found

Title Not Found

Journal: Ugeskrift for laeger

Published: September 30, 2025

Evaluation of point-of-care instrument for quantification of infliximab and adalimumab.

Evaluation of point-of-care instrument for quantification of infliximab and adalimumab.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: September 12, 2025

Acute severe ulcerative colitis without systemic toxicity: A retrospective multicenter cohort study suggesting refining the definition of acute severe ulcerative colitis.

Acute severe ulcerative colitis without systemic toxicity: A retrospective multicenter cohort study suggesting refining the definition of acute severe ulcerative colitis.

Journal: Inflammatory bowel diseases

Published: August 29, 2025

MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT).

MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT).

Journal: BMJ open gastroenterology

Published: July 29, 2025

Editorial: Real-World Effectiveness of Mirikizumab in Ulcerative Colitis-A Valuable but Preliminary Glimpse.

Editorial: Real-World Effectiveness of Mirikizumab in Ulcerative Colitis-A Valuable but Preliminary Glimpse.

Journal: Alimentary pharmacology & therapeutics

Published: April 11, 2025

Neutrophil-mediated degradation of type III collagen is elevated in inflammatory bowel disease and DSS-induced colitis reflecting early mucosal damage.

Neutrophil-mediated degradation of type III collagen is elevated in inflammatory bowel disease and DSS-induced colitis reflecting early mucosal damage.

Journal: Scientific reports

Published: February 19, 2025

Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review.

Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review.

Journal: Basic & clinical pharmacology & toxicology

Published: February 03, 2025

Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations.

Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations.

Journal: Drugs

Published: October 15, 2024

Does filgotinib work for Crohn's disease?

Does filgotinib work for Crohn's disease?

Journal: The lancet. Gastroenterology & hepatology

Published: August 20, 2024

The role of chest X-rays when screening for latent tuberculosis infection in patients with inflammatory bowel disease before starting biologic treatment.

The role of chest X-rays when screening for latent tuberculosis infection in patients with inflammatory bowel disease before starting biologic treatment.

Journal: Scandinavian journal of gastroenterology

Published: June 22, 2024

Showing 1-12 of 67

Last Updated: 09/26/2026